Genomic phenotype of non-cultured pulmonary fibroblasts in idiopathic pulmonary fibrosis

Genomics

Volumn 96, Issue 3, 2010, Pages 134-145

  Emblom Callahan, Margaret C ^a   Chhina, Mantej K ^a   Shlobin, Oksana A ^b   Ahmad, Shahzad ^b   Reese, Erika S ^a   Iyer, Eswar P R ^a   Cox, Daniel N ^a   Brenner, Renee ^b   Burton, Nelson A ^b   Grant, Geraldine M ^a   Nathan, Steven D ^b  

^a GEORGE MASON UNIVERSITY   (United States)

^b INOVA FAIRFAX HOSPITAL   (United States)

Author keywords

Fibroblast; Genomics; Idiopathic pulmonary fibrosis; Microarray

Indexed keywords

ATROGIN 1; BRADYKININ B1 RECEPTOR; CASPASE 6; CXCL14 CHEMOKINE; CYCLIN DEPENDENT KINASE INHIBITOR 2D; NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE; NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE 1; PROTEASOME; PROTEIN BAX; RETINOIC ACID RECEPTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; WNT PROTEIN;

ADULT; APOPTOSIS; ARTICLE; CELL CYCLE REGULATION; CELL METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FIBROSING ALVEOLITIS; GENE CONTROL; GENE EXPRESSION; GENOMICS; HOMEOSTASIS; HUMAN; HUMAN CELL; LUNG FIBROBLAST; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UBIQUITINATION; UPREGULATION; VITAMIN METABOLISM;

EID: 77955638726     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2010.04.005     Document Type: Article

References (86)

1. Dempsey O.J. Clinical review: idiopathic pulmonary fibrosis-past, present and future. Respir. Med. 2006, 100:1871-1885.
2. Scotton C.J., Chambers R.C. Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest 2007, 132:1311-1321.
3. Selman M., Pardo A., Barrera L., Estrada A., Watson S.R., Wilson K., Aziz N., Kaminski N., Zlotnik A. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am. J. Respir. Crit. Care Med. 2006, 173:188-198.
4. Yang I.V., Burch L.H., Steele M.P., Savov J.D., Hollingsworth J.W., McElvania-Tekippe E., Berman K.G., Speer M.C., Sporn T.A., Brown K.K., Schwarz M.I., Schwartz D.A. Gene expression profiling of familial and sporadic interstitial pneumonia. Am. J. Respir. Crit. Care Med. 2007, 175:45-54.
5. Wang J., Chen H., Seth A., McCulloch C.A. Mechanical force regulation of myofibroblast differentiation in cardiac fibroblasts. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:H1871-H1881.
6. Saeed A.I., Sharov V., White J., Li J., Liang W., Bhagabati N., Braisted J., Klapa M., Currier T., Thiagarajan M., Sturn A., Snuffin M., Rezantsev A., Popov D., Ryltsov A., Kostukovich E., Borisovsky I., Liu Z., Vinsavich A., Trush V., Quackenbush J. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003, 34:374-378.
7. Cleveland W.S., Devlin S.J. Locally weighted regression: an approach to regression analysis by local fitting 1988, 596-610. American Statistical Association.
8. Tusher V.G., Tibshirani R., Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl Acad. Sci. USA 2001, 98:5116-5121.
9. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
10. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
11. Dennis G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., Lempicki R.A. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003, 4:P3.
12. Kanehisa M., Goto S., Hattori M., Aoki-Kinoshita K.F., Itoh M., Kawashima S., Katayama T., Araki M., Hirakawa M. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res. 2006, 34:D354-D357.
13. Kanehisa M., Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000, 28:27-30.
14. Kanehisa M., Goto S., Furumichi M., Tanabe M., Hirakawa M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 2010, 38:D355-D360.
15. Elaut G., Henkens T., Papeleu P., Snykers S., Vinken M., Vanhaecke T., Rogiers V. Molecular mechanisms underlying the dedifferentiation process of isolated hepatocytes and their cultures. Curr. Drug Metab. 2006, 7:629-660.
16. Pampaloni F., Reynaud E.G., Stelzer E.H. The third dimension bridges the gap between cell culture and live tissue. Nat. Rev. Mol. Cell Biol. 2007, 8:839-845.
17. Guidry C. Isolation and characterization of porcine Muller cells. Myofibroblastic dedifferentiation in culture. Invest. Ophthalmol. Vis. Sci. 1996, 37:740-752.
18. Starner T.D., Zhang N., Kim G., Apicella M.A., McCray P.B. Haemophilus influenzae forms biofilms on airway epithelia: implications in cystic fibrosis. Am. J. Respir. Crit. Care Med. 2006, 174:213-220.
19. Karp P.H., Moninger T.O., Weber S.P., Nesselhauf T.S., Launspach J.L., Zabner J., Welsh M.J. An in vitro model of differentiated human airway epithelia. Methods for establishing primary cultures. Meth. Mol. Biol. 2002, 188:115-137.
20. Korfei M., Ruppert C., Mahavadi P., Henneke I., Markart P., Koch M., Lang G., Fink L., Bohle R.M., Seeger W., Weaver T.E., Guenther A. Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2008, 178:838-846.
21. Purkerson J.M., Smith R.S., Pollock S.J., Phipps R.P. The TRAF6, but not the TRAF2/3, binding domain of CD40 is required for cytokine production in human lung fibroblasts. Eur. J. Immunol. 2005, 35:2920-2928.
22. Sempowski G.D., Chess P.R., Phipps R.P. CD40 is a functional activation antigen and B7-independent T cell costimulatory molecule on normal human lung fibroblasts. J. Immunol. 1997, 158:4670-4677.
23. Wynn T.A. Cellular and molecular mechanisms of fibrosis. J. Pathol. 2008, 214:199-210.
24. Konigshoff M., Balsara N., Pfaff E.M., Kramer M., Chrobak I., Seeger W., Eickelberg O. Functional Wnt signaling is increased in idiopathic pulmonary fibrosis. PLoS ONE 2008, 3:e2142.
25. Vuga L.J., Ben-Yehudah A., Kovkarova-Naumovski E., Oriss T., Gibson K.F., Feghali-Bostwick C., Kaminski N. WNT5A is a regulator of fibroblast proliferation and resistance to apoptosis. Am. J. Respir. Cell Mol. Biol. 2009, 41:583-589.
26. Chilosi M., Poletti V., Zamo A., Lestani M., Montagna L., Piccoli P., Pedron S., Bertaso M., Scarpa A., Murer B., Cancellieri A., Maestro R., Semenzato G., Doglioni C. Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis. Am. J. Pathol. 2003, 162:1495-1502.
27. Pardo A., Gibson K., Cisneros J., Richards T.J., Yang Y., Becerril C., Yousem S., Herrera I., Ruiz V., Selman M., Kaminski N. Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis. PLoS Med. 2005, 2:e251.
28. Sousa A.M., Liu T., Guevara O., Stevens J., Fanburg B.L., Gaestel M., Toksoz D., Kayyali U.S. Smooth muscle alpha-actin expression and myofibroblast differentiation by TGFbeta are dependent upon MK2. J. Cell. Biochem. 2007, 100:1581-1592.
29. Arora P.D., Bibby K.J., McCulloch C.A. Slow oscillations of free intracellular calcium ion concentration in human fibroblasts responding to mechanical stretch. J. Cell. Physiol. 1994, 161:187-200.
30. Vyalov S.L., Gabbiani G., Kapanci Y. Rat alveolar myofibroblasts acquire alpha-smooth muscle actin expression during bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 1993, 143:1754-1765.
31. Thannickal V.J., Horowitz J.C. Evolving concepts of apoptosis in idiopathic pulmonary fibrosis. Proc. Am. Thorac. Soc. 2006, 3:350-356.
32. Ramos C., Montano M., Garcia-Alvarez J., Ruiz V., Uhal B.D., Selman M., Pardo A. Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression. Am. J. Respir. Cell Mol. Biol. 2001, 24:591-598.
33. Fattman C.L. Apoptosis in pulmonary fibrosis: too much or not enough?. Antioxid. Redox Signal. 2008, 10:379-385.
34. Pardo A., Selman M., Kaminski N. Approaching the degradome in idiopathic pulmonary fibrosis. Int. J. Biochem. Cell Biol. 2008, 40:1141-1155.
35. Glickman M.H., Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 2002, 82:373-428.
36. Reed S.I. The ubiquitin-proteasome pathway in cell cycle control. Results Probl. Cell Differ. 2006, 42:147-181.
37. Hattori T., Kitagawa K., Uchida C., Oda T., Kitagawa M. Cks1 is degraded via the ubiquitin-proteasome pathway in a cell cycle-dependent manner. Genes Cells 2003, 8:889-896.
38. Shimo A., Nishidate T., Ohta T., Fukuda M., Nakamura Y., Katagiri T. Elevated expression of protein regulator of cytokinesis 1, involved in the growth of breast cancer cells. Cancer Sci. 2007, 98:174-181.
39. Bringardner B.D., Baran C.P., Eubank T.D., Marsh C.B. The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis. Antioxid. Redox Signal. 2008, 10:287-301.
40. Kalwitz G., Endres M., Neumann K., Skriner K., Ringe J., Sezer O., Sittinger M., Haupl T., Kaps C. Gene expression profile of adult human bone marrow-derived mesenchymal stem cells stimulated by the chemokine CXCL7. Int. J. Biochem. Cell Biol. 2009, 41:649-658.
41. Andersson-Sjoland A., de Alba C.G., Nihlberg K., Becerril C., Ramirez R., Pardo A., Westergren-Thorsson G., Selman M. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int. J. Biochem. Cell Biol. 2008, 40:2129-2140.
42. Xu J., Mora A., Shim H., Stecenko A., Brigham K.L., Rojas M. Role of the SDF-1/CXCR4 axis in the pathogenesis of lung injury and fibrosis. Am. J. Respir. Cell Mol. Biol. 2007, 37:291-299.
43. Yang Y., Zou L., Li M., Zhao Y. CXCL12/CXCR4 expression in trophoblasts takes part in materno-fetal immune tolerance and vascular remodeling. J. Huazhong Univ. Sci. Technol. Med. Sci. 2006, 26:466-468.
44. Phillips R.J., Burdick M.D., Hong K., Lutz M.A., Murray L.A., Xue Y.Y., Belperio J.A., Keane M.P., Strieter R.M. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J. Clin. Invest. 2004, 114:438-446.
45. Schwarze S.R., Luo J., Isaacs W.B., Jarrard D.F. Modulation of CXCL14 (BRAK) expression in prostate cancer. Prostate 2005, 64:67-74.
46. Shurin G.V., Ferris R.L., Tourkova I.L., Perez L., Lokshin A., Balkir L., Collins B., Chatta G.S., Shurin M.R. Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo. J. Immunol. 2005, 174:5490-5498.
47. Wente M.N., Mayer C., Gaida M.M., Michalski C.W., Giese T., Bergmann F., Giese N.A., Buchler M.W., Friess H. CXCL14 expression and potential function in pancreatic cancer. Cancer Lett. 2008, 259:209-217.
48. Augsten M., Hagglof C., Olsson E., Stolz C., Tsagozis P., Levchenko T., Frederick M.J., Borg A., Micke P., Egevad L., Ostman A. CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth. Proc. Natl Acad. Sci. USA 2009, 106:3414-3419.
49. Frederick M.J., Henderson Y., Xu X., Deavers M.T., Sahin A.A., Wu H., Lewis D.E., El-Naggar A.K., Clayman G.L. In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue. Am. J. Pathol. 2000, 156:1937-1950.
50. Allinen M., Beroukhim R., Cai L., Brennan C., Lahti-Domenici J., Huang H., Porter D., Hu M., Chin L., Richardson A., Schnitt S., Sellers W.R., Polyak K. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004, 6:17-32.
51. Sohn S.H., Kim K.N., Kim I.K., Lee E.I., Ryu J.J., Kim M.K. Effects of tobacco compounds on gene expression in fetal lung fibroblasts. Environ. Toxicol. 2008, 23:423-434.
52. Komura K., Fujimoto M., Yanaba K., Matsushita T., Matsushita Y., Horikawa M., Ogawa F., Shimizu K., Hasegawa M., Takehara K., Sato S. Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse. Ann. Rheum. Dis. 2008, 67:867-872.
53. Uhal B.D., Kim J.K., Li X., Molina-Molina M. Angiotensin-TGF-beta 1 crosstalk in human idiopathic pulmonary fibrosis: autocrine mechanisms in myofibroblasts and macrophages. Curr. Pharm. Des. 2007, 13:1247-1256.
54. Willis B.C., Borok Z. TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 293:L525-L534.
55. Shintani Y., Fukumoto Y., Chaika N., Svoboda R., Wheelock M.J., Johnson K.R. Collagen I-mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1. J. Cell Biol. 2008, 180:1277-1289.
56. Medici D., Hay E.D., Olsen B.R. Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3. Mol. Biol. Cell 2008, 19:4875-4887.
57. Selman M., Pardo A. Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder. Respir. Res. 2002, 3:3.
58. Selman M., King T.E., Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann. Intern. Med. 2001, 134:136-151.
59. West J., Fagan K., Steudel W., Fouty B., Lane K., Harral J., Hoedt-Miller M., Tada Y., Ozimek J., Tuder R., Rodman D.M. Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle. Circ. Res. 2004, 94:1109-1114.
60. Kim Y.M., Jeon E.S., Kim M.R., Lee J.S., Kim J.H. Bradykinin-induced expression of alpha-smooth muscle actin in human mesenchymal stem cells. Cell. Signal. 2008, 20:1882-1889.
61. Wang P.H., Cenedeze M.A., Campanholle G., Malheiros D.M., Torres H.A., Pesquero J.B., Pacheco-Silva A., Camara N.O. Deletion of bradykinin B1 receptor reduces renal fibrosis. Int. Immunopharmacol. 2009, 9:653-657.
62. Zaitseva M., Vollenhoven B.J., Rogers P.A. Retinoic acid pathway genes show significantly altered expression in uterine fibroids when compared with normal myometrium. Mol. Hum. Reprod. 2007, 13:577-585.
63. Okuno M., Kojima S., Akita K., Matsushima-Nishiwaki R., Adachi S., Sano T., Takano Y., Takai K., Obora A., Yasuda I., Shiratori Y., Okano Y., Shimada J., Suzuki Y., Muto Y., Moriwaki Y. Retinoids in liver fibrosis and cancer. Front. Biosci. 2002, 7:d204-d218.
64. Bour G., Lalevee S., Rochette-Egly C. Protein kinases and the proteasome join in the combinatorial control of transcription by nuclear retinoic acid receptors. Trends Cell Biol. 2007, 17:302-309.
65. Bastien J., Rochette-Egly C. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 2004, 328:1-16.
66. Zhang T., Kraus W.L. SIRT1-dependent regulation of chromatin and transcription: Linking NAD(+) metabolism and signaling to the control of cellular functions. Biochim. Biophys. Acta 2009, 1804:1666-1675.
67. Michan S., Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem. J. 2007, 404:1-13.
68. Berger F., Lau C., Ziegler M. Regulation of poly(ADP-ribose) polymerase 1 activity by the phosphorylation state of the nuclear NAD biosynthetic enzyme NMN adenylyl transferase 1. Proc. Natl Acad. Sci. USA 2007, 104:3765-3770.
69. Lo A.S., Liew C.T., Ngai S.M., Tsui S.K., Fung K.P., Lee C.Y., Waye M.M. Developmental regulation and cellular distribution of human cytosolic malate dehydrogenase (MDH1). J. Cell. Biochem. 2005, 94:763-773.
70. Lee S.M., Kim J.H., Cho E.J., Youn H.D. A nucleocytoplasmic malate dehydrogenase regulates p53 transcriptional activity in response to metabolic stress. Cell Death Differ. 2009, 16:738-748.
71. Senner V., Ratzinger S., Mertsch S., Grassel S., Paulus W. Collagen XVI expression is upregulated in glioblastomas and promotes tumor cell adhesion. FEBS Lett. 2008, 582:3293-3300.
72. Kassner A., Tiedemann K., Notbohm H., Ludwig T., Morgelin M., Reinhardt D.P., Chu M.L., Bruckner P., Grassel S. Molecular structure and interaction of recombinant human type XVI collagen. J. Mol. Biol. 2004, 339:835-853.
73. Scheele S., Nystrom A., Durbeej M., Talts J.F., Ekblom M., Ekblom P. Laminin isoforms in development and disease. J. Mol. Med. 2007, 85:825-836.
74. Ashida S., Nakagawa H., Katagiri T., Furihata M., Iiizumi M., Anazawa Y., Tsunoda T., Takata R., Kasahara K., Miki T., Fujioka T., Shuin T., Nakamura Y. Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: genome-wide gene-expression profiles of prostate cancers and PINs. Cancer Res. 2004, 64:5963-5972.
75. Huang X., Ji G., Wu Y., Wan B., Yu L. LAMA4, highly expressed in human hepatocellular carcinoma from Chinese patients, is a novel marker of tumor invasion and metastasis. J. Cancer Res. Clin. Oncol. 2008, 134:705-714.
76. Hamilton D.W. Functional role of periostin in development and wound repair: implications for connective tissue disease. J. Cell Commun. Signal 2008, 2:9-17.
77. Takayama G., Arima K., Kanaji T., Toda S., Tanaka H., Shoji S., McKenzie A.N., Nagai H., Hotokebuchi T., Izuhara K. Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J. Allergy Clin. Immunol. 2006, 118:98-104.
78. Oku E., Kanaji T., Takata Y., Oshima K., Seki R., Morishige S., Imamura R., Ohtsubo K., Hashiguchi M., Osaki K., Yakushiji K., Yoshimoto K., Ogata H., Hamada H., Izuhara K., Sata M., Okamura T. Periostin and bone marrow fibrosis. Int. J. Hematol. 2008, 88:57-63.
79. Takanami I., Abiko T., Koizumi S. Expression of periostin in patients with non-small cell lung cancer: correlation with angiogenesis and lymphangiogenesis. Int. J. Biol. Markers 2008, 23:182-186.
80. Shao R., Bao S., Bai X., Blanchette C., Anderson R.M., Dang T., Gishizky M.L., Marks J.R., Wang X.F. Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression. Mol. Cell. Biol. 2004, 24:3992-4003.
81. Kobayashi K., Luo M., Zhang Y., Wilkes D.C., Ge G., Grieskamp T., Yamada C., Liu T.C., Huang G., Basson C.T., Kispert A., Greenspan D.S., Sato T.N. Secreted Frizzled-related protein 2 is a procollagen C proteinase enhancer with a role in fibrosis associated with myocardial infarction. Nat. Cell Biol. 2009, 11:46-55.
82. Yamamura H., Hirano N., Koyama H., Nishizawa Y., Takahashi K. Loss of smooth muscle calponin results in impaired blood vessel maturation in the tumor-host microenvironment. Cancer Sci. 2007, 98:757-763.
83. Fukui Y., Masuda H., Takagi M., Takahashi K., Kiyokane K. The presence of h2-calponin in human keratinocyte. J. Dermatol. Sci. 1997, 14:29-36.
84. Hossain M.M., Hwang D.Y., Huang Q.Q., Sasaki Y., Jin J.P. Developmentally regulated expression of calponin isoforms and the effect of h2-calponin on cell proliferation. Am. J. Physiol. Cell Physiol. 2003, 284:C156-C167.
85. Larsson O., Diebold D., Fan D., Peterson M., Nho R.S., Bitterman P.B., Henke C.A. Fibrotic myofibroblasts manifest genome-wide derangements of translational control. PLoS ONE 2008, 3:e3220.
86. Nasreen F., Altaf Malik N., Naeem Riaz M., Anver Qureshi J. Detection and screening of bovine leukocyte adhesion deficiency in Pakistan using molecular methods. Hereditas 2009, 146:74-78.